TerrAscend (OTCMKTS:TRSSF) Trading 1% Higher - Here's Why

Key Points

• Shares traded 1% higher279% increase versus average daily volume.
• The company has a market capitalization of $165.98 million and a negative P/E (-4.71), with leverage and liquidity metrics showing a debt-to-equity of 0.55, current ratio 0.73 and quick ratio 0.40; the stock is volatile (beta 2.89) and trading near its 50‑day ($0.65) and 200‑day ($0.67) moving averages.
• TerrAscend is a vertically integrated cannabis company operating cultivation, processing and retail across key U.S. markets (Pennsylvania, New Jersey, California) and Canadian provincial channels, spanning the full value chain from cultivation to retail.

TerrAscend Corp. (OTCMKTS:TRSSF - Get Free Report) shares rose 1% on Monday . The stock traded as high as $0.6890 and last traded at $0.6590. Approximately 496,378 shares were traded during trading, an increase of 279% from the average daily volume of 131,026 shares. The stock had previously closed at $0.6526.

TerrAscend Price Performance

The company has a debt-to-equity ratio of 0.55, a current ratio of 0.73 and a quick ratio of 0.40. The stock has a market capitalization of $165.98 million, a price-to-earnings ratio of -4.71 and a beta of 2.89. The stock's 50 day simple moving average is $0.65 and its 200-day simple moving average is $0.67.

About TerrAscend

TerrAscend Corp. is a vertically integrated cannabis company operating across key markets in the United States and Canada. The company holds cultivation, processing and retail licenses in several U.S. jurisdictions—including Pennsylvania, New Jersey and California—while its Canadian operations serve both medical and adult-use markets through provincial distribution channels. TerrAscend's business model spans the full value chain from cultivation and extraction to manufacturing and retail.

In its U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.